Rights and permissions
About this article
Cite this article
Failure of initial IV antibacterials could cost US healthcare millions. Pharmacoecon. Outcomes News 489, 6 (2005). https://doi.org/10.2165/00151234-200504890-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504890-00013